No Data
No Data
Option Care Health to Participate in Upcoming Investor Conferences
Truist Financial Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $34
Goldman Shifts Option Care Health to Neutral, Cites Looming Profit Concerns
Goldman Sachs Downgrades Option Care Health(OPCH.US) to Hold Rating, Cuts Target Price to $27
Option Care Health Downgraded to Neutral at Goldman on Stelara Headwinds
Option Care Health Downgraded to Neutral From Buy at Goldman Sachs